Income Statement
AGIOS PHARMACEUTICALS, INC.
AGIO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
54.03 | 36.50 | 26.82 | 14.24 | - | 203.20 | 117.91 | 94.39 | 43.01 | - | - | 65.40 | 25.55 |
|
Cost of Revenue
|
6.35 | 4.17 | 2.88 | 1.70 | - | 2.81 | 1.32 | 1.40 | - | - | - | - | - |
|
Gross Profit
|
47.68 | 32.33 | 23.94 | 12.54 | - | 200.39 | 116.60 | 92.99 | 43.01 | - | - | 65.40 | 25.55 |
|
Operating Expenses
|
519.82 | 458.07 | 415.43 | 401.58 | 378.42 | 516.54 | 542.93 | 456.87 | 363.81 | 270.88 | 177.82 | 119.49 | 64.43 |
|
Research & Development
|
339.54 | 301.29 | 295.53 | 279.91 | 256.97 | 367.47 | 410.89 | 341.32 | 292.68 | 220.16 | 141.83 | 100.37 | 54.50 |
|
Selling, General & Administrative
|
180.28 | 156.78 | 119.90 | 121.67 | 121.45 | 149.07 | 132.03 | 114.15 | 71.12 | 50.71 | 35.99 | 19.12 | 9.93 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-472.13 | -425.74 | -391.49 | -389.05 | -378.42 | -316.15 | -426.33 | -363.88 | -320.79 | -270.88 | -177.82 | -54.09 | -38.88 |
|
Non-Operating Income
|
-58.34 | -1,143.71 | -39.40 | -157.25 | -21.91 | - | - | - | - | -72.41 | -60.09 | -0.16 | -0.06 |
|
Interest Income
|
- | - | - | 12.79 | 0.84 | 6.61 | 14.86 | 16.45 | 6.12 | 2.51 | 0.97 | 0.20 | 0.06 |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
1.96 | 6.49 | 6.06 | 6.75 | 14.43 | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-413.80 | 717.97 | -352.09 | -231.80 | -356.51 | -327.45 | -411.47 | -346.03 | -314.67 | -198.47 | -117.73 | -53.93 | -38.83 |
|
Income Tax Expense
|
-1.02 | 44.24 | 0.00 | 0.00 | -1,961.23 | - | - | - | - | 0.00 | 0.00 | -0.43 | 0.58 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-412.78 | 673.73 | -352.09 | -231.80 | 1,604.72 | -327.37 | -411.47 | -346.03 | -314.67 | -198.47 | -117.73 | -53.50 | -39.41 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-472.13 | -425.74 | -391.49 | -389.05 | -378.42 | -316.15 | -418.25 | -363.88 | -320.79 | -270.88 | -177.82 | -54.09 | -38.88 |
|
Earnings Per Share (Basic)
|
-7.12 | 11.86 | -6.33 | -4.23 | 26.55 | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-7.12 | 11.64 | -6.33 | -4.23 | 26.55 | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
57.97 | 56.81 | 55.65 | 54.79 | 60.45 | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
57.97 | 57.89 | 55.65 | 54.79 | 60.45 | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-409.07 | 672.65 | -339.99 | -243.14 | 1,603.41 | -327.47 | -409.10 | -1.22 | -315.75 | -198.47 | -117.99 | -53.58 | -39.39 |